In vivo evaluation of cetuximab-conjugated poly(γ-glutamic acid)-docetaxel nanomedicines in EGFR-overexpressing gastric cancer xenografts [Corrigendum]

Código QR

In vivo evaluation of cetuximab-conjugated poly(γ-glutamic acid)-docetaxel nanomedicines in EGFR-overexpressing gastric cancer xenografts [Corrigendum]

Sreeranganathan M, Uthaman S, Sarmento B, et al. Int J Nanomedicine. 2017;12:7165–7182.   When reviewing the paper, the authors noted some errors in Figure 2E (page 7171) and Figure 6 (page 7176). They confirm that the corrections to Figures 2 and 6 do n...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Sreeranganathan M, Uthaman S, Sarmento B, Mohan CG, Park IK, Jayakumar R
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2019
Materias:	Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/c2f4c508825840b29596534c2409cbb6
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

In vivo evaluation of cetuximab-conjugated poly(γ-glutamic acid)-docetaxel nanomedicines in EGFR-overexpressing gastric cancer xenografts
por: Sreeranganathan M, et al.
Publicado: (2017)

Design of theranostic nanomedicine (II): synthesis and physicochemical properties of a biocompatible polyphosphazene–docetaxel conjugate
por: Jun YJ, et al.
Publicado: (2017)

Anti-EGFR antibody 528 binds to domain III of EGFR at a site shifted from the cetuximab epitope
por: Koki Makabe, et al.
Publicado: (2021)

Cetuximab-conjugated iron oxide nanoparticles for cancer imaging and therapy
por: Tseng SH, et al.
Publicado: (2015)

EGFR targeted therapy in non-small cell lung cancer: potential role of cetuximab
por: Chad A Reade, et al.
Publicado: (2009)

Activity of docetaxel, carboplatin, and doxorubicin in patient-derived triple-negative breast cancer xenografts
por: Miguel Martin, et al.
Publicado: (2021)

Cetuximab-Coated Thermo-Sensitive Liposomes Loaded with Magnetic Nanoparticles and Doxorubicin for Targeted EGFR-Expressing Breast Cancer Combined Therapy
por: Dorjsuren B, et al.
Publicado: (2020)

EGFR Targeted Cetuximab-Valine-Citrulline (vc)-Doxorubicin Immunoconjugates- Loaded Bovine Serum Albumin (BSA) Nanoparticles for Colorectal Tumor Therapy
por: Ye Z, et al.
Publicado: (2021)

Overexpression of Ras homologous C (RhoC) induces malignant transformation of hepatocytes in vitro and in nude mouse xenografts.
por: Shuli Xie, et al.
Publicado: (2013)

Synthesis, characterization, and in vivo efficacy evaluation of PGG&ndash;docetaxel conjugate for potential cancer chemotherapy
por: Jiang X, et al.
Publicado: (2012)

Cetuximab and biomarkers in non-small-cell lung carcinoma
por: Patil N, et al.
Publicado: (2012)

GE11 peptide-conjugated nanoliposomes to enhance the combinational therapeutic efficacy of docetaxel and siRNA in laryngeal cancers
por: Xu WW, et al.
Publicado: (2017)

A facile doxorubicin-dichloroacetate conjugate nanomedicine with high drug loading for safe drug delivery
por: Yang CL, et al.
Publicado: (2018)

In vitro removal of toxic heavy metals by poly(&gamma;-glutamic acid)-coated superparamagnetic nanoparticles
por: Inbaraj BS, et al.
Publicado: (2012)

Photothermal-modulated drug delivery and magnetic relaxation based on collagen/poly(γ-glutamic acid) hydrogel
por: Cho SH, et al.
Publicado: (2017)

Multicellular tumor spheroids for evaluation of cytotoxicity and tumor growth inhibitory effects of nanomedicines in vitro: a comparison of docetaxel-loaded block copolymer micelles and Taxotere®.
por: Andrew S Mikhail, et al.
Publicado: (2013)

Glutamic acid–valine–citrulline linkers ensure stability and efficacy of antibody–drug conjugates in mice
por: Yasuaki Anami, et al.
Publicado: (2018)

Wheat Germ Agglutinin-Conjugated Disulfide Cross-Linked Alginate Nanoparticles as a Docetaxel Carrier for Colon Cancer Therapy
por: Chiu HI, et al.
Publicado: (2021)

Preparation and characterization of self-assembled nanoparticles based on low-molecular-weight heparin and stearylamine conjugates for controlled delivery of docetaxel
por: Kim DH, et al.
Publicado: (2014)

Fabrication of a triptolide-loaded and poly-γ-glutamic acid-based amphiphilic nanoparticle for the treatment of rheumatoid arthritis
por: Zhang L, et al.
Publicado: (2018)

Cetuximab: its unique place in head and neck cancer treatment
por: Specenier P, et al.
Publicado: (2013)

The contribution of cetuximab in the treatment of recurrent and/or metastatic head and neck cancer
por: Mohamedtaki A Tejani, et al.
Publicado: (2010)

Publisher Correction: Revealing membrane alteration in cells overexpressing CA IX and EGFR by Surface-Enhanced Raman Scattering
por: Giulia Rusciano, et al.
Publicado: (2019)

Ankyrin Repeat Domain 1 Overexpression is Associated with Common Resistance to Afatinib and Osimertinib in EGFR-mutant Lung Cancer
por: Akiko Takahashi, et al.
Publicado: (2018)

Development and optimization of oil-filled lipid nanoparticles containing docetaxel conjugates designed to control the drug release rate in vitro and in vivo
por: Feng L, et al.
Publicado: (2011)

Hair dye-incorporated poly-&gamma;-glutamic acid/glycol chitosan nanoparticles based on ion-complex formation
por: Lee HY, et al.
Publicado: (2011)

Fabrication of a triptolide-loaded and poly-γ-glutamic acid-based amphiphilic nanoparticle for the treatment of rheumatoid arthritis [Corrigendum]
por: Zhang L, et al.
Publicado: (2019)

Transgenic overexpression of Tcfap2c/AP-2gamma results in liver failure and intestinal dysplasia.
por: Daniel Holl, et al.
Publicado: (2011)

The use of radiocobalt as a label improves imaging of EGFR using DOTA-conjugated Affibody molecule
por: Javad Garousi, et al.
Publicado: (2017)

Genomic characterization of intrinsic and acquired resistance to cetuximab in colorectal cancer patients
por: Steven M. Bray, et al.
Publicado: (2019)

Different responses of colorectal cancer cells to alternative sequences of cetuximab and oxaliplatin
por: Elli Narvi, et al.
Publicado: (2018)

Comparison of anti-EGFR-Fab’ conjugated immunoliposomes modified with two different conjugation linkers for siRNA delivery in SMMC-7721 cells
por: Deng L, et al.
Publicado: (2013)

Combined FGFR and Akt pathway inhibition abrogates growth of FGFR1 overexpressing EGFR-TKI-resistant NSCLC cells
por: Mikkel G. Terp, et al.
Publicado: (2021)

Surface Engineering of Escherichia coli–Derived OMVs as Promising Nano-Carriers to Target EGFR-Overexpressing Breast Cancer Cells
por: Zahra Sepahdar, et al.
Publicado: (2021)

Development of AE147 Peptide-Conjugated Nanocarriers for Targeting uPAR-Overexpressing Cancer Cells
por: Park JY, et al.
Publicado: (2021)

Design of a novel theranostic nanomedicine: synthesis and physicochemical properties of a biocompatible polyphosphazene–platinum(II) conjugate
por: Avaji PG, et al.
Publicado: (2016)

Nanomedicine journal

Author Correction: ABCG2-overexpressing H460/MX20 cell xenografts in athymic nude mice maintained original biochemical and cytological characteristics
por: Wei Zhang, et al.
Publicado: (2020)

Interleukin‐33 as an early predictor of cetuximab treatment efficacy in patients with colorectal cancer
por: Xujun Zhang, et al.
Publicado: (2021)

Practical preparation procedures for docetaxel-loaded nanoparticles using polylactic acid-co-glycolic acid
por: Keum CG, et al.
Publicado: (2011)